The results showed that circMBOAT2 was not significantly enriched by the AGO2 antibody (Fig. S4A, B), suggesting that circMBOAT2 may not act as a miRNA sponge during ICC progression. Here, AGO2 is linked to intrahepatic cholangiocarcinoma.